| 1 |
Zhou S, Jin Q, Yao H, Ying J, Tian L, Jiang X, Yang Y, Jiang X, Gao W, Zhang W, Zhu Y, Cao W. Pain-Related Gene Solute Carrier Family 24 Member 3 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma: A Study via Integrated Bioinformatics Analyses and Experimental Verification. Comput Math Methods Med 2023;2023:4164232. [PMID: 36798148 DOI: 10.1155/2023/4164232] [Reference Citation Analysis]
|
| 2 |
Wang K, Chen Y, Zhang Y, Liu S, Ao M, Yang H, Li B. Exploration of Immunogenic Cell Death-Associated Genes for Predicting Prognosis and Immunological Characteristics in Cervical Squamous Cell Carcinoma. Journal of Oncology 2023;2023:1-13. [DOI: 10.1155/2023/1405635] [Reference Citation Analysis]
|
| 3 |
Xing X, Tian Y, Jin X. Immune infiltration and a necroptosis-related gene signature for predicting the prognosis of patients with cervical cancer. Front Genet 2022;13:1061107. [PMID: 36685937 DOI: 10.3389/fgene.2022.1061107] [Reference Citation Analysis]
|
| 4 |
Xie Y, Kong W, Zhao X, Zhang H, Luo D, Chen S. Immune checkpoint inhibitors in cervical cancer: Current status and research progress. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.984896] [Reference Citation Analysis]
|
| 5 |
Yang B, Wang Z, Deng Y, Xiao L, Zhang K. LncRNA LAMTOR5-AS1 sponges miR-210-3p and regulates cervical cancer progression. J Obstet Gynaecol Res 2022. [PMID: 36173004 DOI: 10.1111/jog.15439] [Reference Citation Analysis]
|
| 6 |
Liu X, Zhang X, Liu C, Mu W, Peng J, Song K. Immune and inflammation: related factor alterations as biomarkers for predicting prognosis and responsiveness to PD-1 monoclonal antibodies in cervical cancer. Discov Oncol 2022;13:96. [PMID: 36171464 DOI: 10.1007/s12672-022-00560-8] [Reference Citation Analysis]
|
| 7 |
Sudha B, Poornima A, Suganya K, Swathi K, Kumar NS, Sumathi S, Chellapandi P. Identification of hub genes and role of CDKN2A as a biomarker in cervical cancer: An in-silico approach. Human Gene 2022;33:201048. [DOI: 10.1016/j.humgen.2022.201048] [Reference Citation Analysis]
|
| 8 |
Xu H, Wang H, Xing T, Wang X. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes. Front Immunol 2022;13:851622. [DOI: 10.3389/fimmu.2022.851622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Qu X, Shi Z, Guo J, Guo C, Qiu J, Hua K. Identification of a novel six-gene signature with potential prognostic and therapeutic value in cervical cancer. Cancer Med 2021;10:6881-96. [PMID: 34498424 DOI: 10.1002/cam4.4054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
